Boston Scientific Executive and Leadership Team

Bernardo Del, the Director, Finance (Country & Chief Financial Officer (Mexico) at Boston Scientific, manages the fiscal health and financial planning for regional operations. Overseeing capital allocation and budgetary compliance, the Director, Finance (Country & Chief Financial Officer (Mexico) ensures that financial resources align with the strategic goals of the MedSurg and Cardiovascular segments. This leadership role involves mitigating financial risks and optimizing cost structures to support the expansion of minimally invasive technologies. By providing rigorous financial oversight and strategic forecasting, Bernardo Del directly impacts the company's profitability and operational stability in the region. Ultimately, the Director, Finance (Country & Chief Financial Officer (Mexico) secures the financial foundation necessary for the organization to continue delivering high-quality medical solutions to healthcare providers and patients.

Peter Pattison, the Global President, Interventional Oncology and Embolization at Boston Scientific, leads the strategic direction and commercialization efforts for the oncology and embolization business units. Overseeing the global product roadmap and market expansion, the Global President, Interventional Oncology and Embolization ensures that advanced interventional solutions are accessible to clinicians treating complex conditions. This leadership role involves coordinating with R&D and clinical teams to accelerate the development of specialized devices that improve patient outcomes in oncology. By driving global growth strategies and fostering innovation, Peter Pattison directly impacts the company's leadership position in the interventional space. Ultimately, the Global President, Interventional Oncology and Embolization secures the long-term success of these critical segments by delivering high-impact medical technologies that address significant unmet needs in the global healthcare market.

Deniz Özgünay, the Commercial Excellence Analyst and Chief of Staff - Growth Emerging Markets at Boston Scientific, drives data-driven strategies to accelerate market adoption in high-growth regions. Overseeing the integration of commercial analytics with operational planning, the Commercial Excellence Analyst and Chief of Staff - Growth Emerging Markets ensures that sales teams possess the insights necessary to capture emerging opportunities. This leadership role involves coordinating cross-functional projects that streamline go-to-market processes for interventional specialties. By refining performance metrics and identifying untapped clinical segments, Deniz Özgünay directly impacts the company's revenue trajectory in developing territories. Ultimately, the Commercial Excellence Analyst and Chief of Staff - Growth Emerging Markets optimizes resource allocation to maximize the impact of medical device portfolios across diverse international healthcare environments.

Janna Berkholtz, the Chief Technology Officer & Vice President, Enterprise Technology & Innovation at Boston Scientific, architects the digital infrastructure and innovation roadmap for the entire organization. Overseeing the development of enterprise-wide technological platforms, the Chief Technology Officer & Vice President, Enterprise Technology & Innovation ensures that internal systems support the rapid commercialization of minimally invasive devices. This leadership role involves collaborating with R&D teams to integrate advanced software solutions into the existing product ecosystem. By modernizing data architecture and fostering a culture of technical excellence, Janna Berkholtz directly impacts the company's ability to scale operations and improve clinical efficiency. Ultimately, the Chief Technology Officer & Vice President, Enterprise Technology & Innovation maintains the technological edge required to sustain long-term leadership in the global medical device industry.

Joseph Bockover, the Manager, Area Business & Strategy Chief of Staff at Boston Scientific, coordinates strategic initiatives and operational workflows across the business area. Overseeing the execution of high-priority projects, the Manager, Area Business & Strategy Chief of Staff ensures that departmental activities remain synchronized with the broader corporate mission. This leadership role involves facilitating communication between executive leadership and operational teams to streamline decision-making processes. By analyzing market trends and operational performance, Joseph Bockover directly impacts the company's ability to respond to evolving clinical needs. Ultimately, the Manager, Area Business & Strategy Chief of Staff drives organizational efficiency and supports the successful implementation of business strategies that enhance the delivery of catheters, stents, and other critical cardiac devices to the global market.

Rafael Carbunaru, the Chief Technology Officer, Neuromodulation at Boston Scientific, leads the technical development and engineering strategy for the neuromodulation product line. Overseeing the design and testing of advanced neuro-stimulation devices, the Chief Technology Officer, Neuromodulation ensures that all products meet rigorous clinical standards and patient safety requirements. This leadership role involves directing R&D efforts to pioneer new therapeutic applications for chronic pain and neurological conditions. By bridging the gap between complex engineering and clinical practice, Rafael Carbunaru directly impacts the company's innovation pipeline and market competitiveness. Ultimately, the Chief Technology Officer, Neuromodulation advances the development of sophisticated medical technologies that provide life-changing relief to patients, reinforcing the company's commitment to improving outcomes through specialized, minimally invasive interventional solutions.

Olga Canny, the Senior Director, Program Management & Chief of Staff at Boston Scientific, governs the lifecycle of critical programs and ensures operational alignment across the organization. Overseeing the execution of complex cross-functional initiatives, the Senior Director, Program Management & Chief of Staff maintains strict adherence to project timelines and quality standards. This leadership role involves managing the intersection of product development and commercial strategy to ensure seamless delivery of medical solutions. By optimizing internal processes and fostering collaboration, Olga Canny directly impacts the company's ability to bring new technologies to market efficiently. Ultimately, the Senior Director, Program Management & Chief of Staff drives the operational excellence required to support the company's mission of providing advanced, minimally invasive technologies to healthcare providers worldwide.

Brian Dunkin, the Chief Medical Officer at Boston Scientific, provides clinical leadership and guides the medical strategy for the entire product portfolio. Overseeing the clinical evidence generation and medical affairs functions, the Chief Medical Officer ensures that all devices align with the highest standards of patient care and clinical efficacy. This leadership role involves collaborating with healthcare professionals to understand emerging clinical needs and translating those insights into product development priorities. By championing evidence-based medicine and safety, Brian Dunkin directly impacts the company's reputation and the success of its interventional technologies. Ultimately, the Chief Medical Officer secures the clinical integrity of the organization, ensuring that every innovation contributes meaningfully to improved patient outcomes and the advancement of minimally invasive medical practices globally.

Chang Kim, the Head of Country at Boston Scientific, directs all regional operations and strategic initiatives to ensure market penetration. Overseeing the alignment of local healthcare requirements with global product standards, the Head of Country manages complex regulatory landscapes and distribution networks. This leadership role involves fostering relationships with key medical institutions to expand the reach of minimally invasive technologies. By optimizing supply chain logistics and local market engagement, Chang Kim directly impacts the company's ability to deliver advanced cardiac and interventional solutions. Ultimately, the Head of Country secures sustainable growth and strengthens the competitive position of the organization within the regional medical device sector through consistent execution of corporate objectives and localized clinical support strategies.

Brad Pulaski, the Regional Executive at Boston Scientific, directs the commercial strategy and operational performance within a designated geographic territory. Overseeing the sales and marketing teams, the Regional Executive ensures that the company's portfolio of catheters, stents, and cardiac devices reaches healthcare providers effectively. This leadership role involves managing regional market dynamics and building strategic partnerships with hospital systems to drive adoption of minimally invasive technologies. By optimizing sales force effectiveness and monitoring regional market trends, Brad Pulaski directly impacts the company's revenue growth and market share. Ultimately, the Regional Executive maintains a strong presence in the field, ensuring that the organization meets the specific clinical and operational demands of the regional healthcare landscape while upholding the company's global standards for quality and service.